Curida Launches New Website & Brand Refresh

Curida Launches it's unified Brand and Website on its 10th Anniversary, Signaling a New Era for the European CDMO

[Oslo, Norway – September 2025] – Curida AS, a leading European Contract Development and Manufacturing Organisation (CDMO), has celebrated its 10th anniversary and officially launched its new website and unified brand identity with an event at its facility in Elverum, just outside Oslo. This facility has been producing pharmaceuticals for over 50 years, and retains some of those people, skills and knowledge even today!

Local dignitaries and leadership, old and new, joined the Curida team on the 29th of August to celebrate this strategic move which reflects Curida’s evolution into a full-spectrum CDMO partner for both pharmaceutical and diagnostic companies, offering a consolidated view of its capabilities, expertise, and growth ambitions. The update brings together Curida’s three business units under a single, integrated brand — now accessible at www.curida.no “We’ve grown significantly over the past few years, both in services and customers across multiple regions and in terms of scope and geography,” said Anders Larsson, CEO of Curida. “Bringing all parts of the business together under one name and one platform is a natural next step — and an important signal to the market that we are a unified partner, ready to deliver at scale and with speed.”

With the launch of its new brand and website, Curida is showcasing a sharper, clearer offering to current and future partners. The company’s consolidated capabilities now include:

🔹 Nasal Spray & Ophthalmic Solutions, including drug product manufacturing and development for uni-dose and multi-dose formats and for suspensions & Controlled drugs.
🔹 End-to-end CDMO support from early development and tech transfer to commercial-scale manufacturing
🔹 Specialised Biologics & Diagnostic Solutions, including monoclonal antibody manufacturing for IVD.
🔹 Pharmacy Formulations – Specialised pharmaceutical manufacturing for Norwegian pharmacies and cosmetic and nutrition clients.

Curida’s expertise spans a diverse range of therapeutic areas, including respiratory care, ophthalmology, pain, wound care, and more — with a strong track record of delivering quality-driven solutions to global pharma and diagnostic clients.
Investing in Growth and Quality

The consolidated brand reflects a broader wave of strategic investments across Curida’s sites, people, and platforms. With a growing and diverse team across Europe, the company continues to build on its commitment to quality, delivery, and agility in a fast-changing market. “Our focus is on being a responsive, high-quality CDMO partner — one that understands our customers' timelines and challenges,” added Larsson. The brand reflects who we are: forward-looking, unified, and driven to support better patient outcomes through trusted partnerships.”

The newly launched website, www.curida.no, offers a more intuitive and informative experience for visitors, showcasing the company’s full capabilities and values in one place.